The biology of hypoxia: The role of oxygen sensing in development, normal function, and disease

Genes and Development

Volumn 18, Issue 18, 2004, Pages 2183-2194

  Giaccia, Amato J ^a   Simon, M Celeste ^b   Johnson, Randall ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

HIF; Hydroxylases; Hypoxia; Ion channels

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ION CHANNEL; OXYGEN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; REACTIVE OXYGEN METABOLITE;

CARCINOGENESIS; CONFERENCE PAPER; EUKARYOTE; HOMEOSTASIS; HYPOXIA; MITOCHONDRION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROKARYOTE; PROTEIN FOLDING; PROTEIN SYNTHESIS;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANOXIA; ENZYMES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; ION CHANNELS; MITOCHONDRIA; NEOPLASMS; OXYGEN; PROTEIN BIOSYNTHESIS; REACTIVE OXYGEN SPECIES; REFERENCE VALUES;

EUKARYOTA; PROKARYOTA;

EID: 4444257379     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1243304     Document Type: Conference Paper

References (70)

1. Aebersold, D.M., Burri, P., Beer, K.T., Laissue, J., Djonov, V., Greiner, R.H., and Semenza, G.L. 2001. Expression of hypoxia-inducible factor-1α: A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 61: 2911-2916.
2. 2 sensing in the human ductus arteriosus: Redox-sensitive K+ channels are regulated by mitochondria-derived hydrogen peroxide. Biol. Chem. 385: 205-216.
3. Arsham, A.M., Howell, J.J., and Simon, M.C. 2003. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J. Biol. Chem. 278: 29655-29660.
4. Bannister, A.J. and Kouzarides, T. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384: 641-643.
5. Bemis, L., Chan, D.A., Finkielstein, C.V., Qi, L., Sutphin, P.D., Chen, X., Stenmark, K., Giaccia, A.J., and Zundel, W. 2004. Distinct aerobic and hypoxic mechanisms of HIF-a regulation by CSN5. Genes & Dev. 18: 739-744.
6. Berra, E., Benizri, E., Ginouves, A., Volmat, V., Roux, D., and Pouyssegur, J. 2003. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J. 22: 4082-4090.
7. Brown, J.M. and Wilson, W.R. 2004. Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer 4: 437-447.
8. Brugarolas, J.B., Vazquez, F., Reddy, A., Sellers, W.R., and Kaelin Jr., W.G. 2003. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell 4: 147-158.
9. Carrero, P., Okamoto, K., Coumailleau, P., O'Brien, S., Tanaka, H., and Poellinger, L. 2000. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1α. Mol. Cell. Biol. 20: 402-415.
10. Compernolle, V., Brusselmans, K., Acker, T., Hoet, P., Tjwa, M., Beck, H., Plaisance, S., Dor, Y., Keshet, E., Lupu, F., et al. 2002. Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat. Med. 8: 702-710.
11. Depping, R., Hagele, S., Wagner, K.F., Wiesner, R.J., Camenisch, G., Wenger, R.H., and Katschinski, D.M. 2004. A dominant-negative isoform of hypoxia-inducible factor-1α specifically expressed in human testis. Biol. Reprod. 71: 331-339.
12. Elson, D.A., Thurston, G., Huang, L.E., Ginzinger, D.G., McDonald, D.M., Johnson, R.S., and Arbeit, J.M. 2001. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1α. Genes & Dev. 15: 2520-2532.
13. Ema, M., Taya, S., Yokotani, N., Sogawa, K., Matsuda, Y., and Fujii-Kuriyama, Y. 1997. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. 94: 4273-4278.
14. Ema, M., Hirota, K., Mimura, J., Abe, H., Yodoi, J., Sogawa, K., Poellinger, L., and Fujii-Kuriyama, Y. 1999. Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia: Their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 18: 1905-1914.
15. Fujio, Y., Nguyen, T., Wencker, D., Kitsis, R.N., and Walsh, K. 2000. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101: 660-667.
16. Garcia-Barros, M., Paris, F., Cordon-Cardo, C., Lyden, D., Rafii, S., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. 2003. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300: 1155-1159.
17. Ghabrial, A., Luschnig, S., Metzstein, M.M., and Krasnow, M.A. 2003. Branching morphogenesis of the Drosophila tracheal system. Annu. Rev. Cell Dev. Biol. 19: 623-647.
18. Gorr, T.A., Tomita, T., Wappner, P., and Bunn, H.F. 2004. Regulation of Drosophila HIF activity in SL2 cells: Identification of a hypoxia-induced variant isoform of the HIFa homologue gene similar. J. Biol. Chem. (in press).
19. Gu, Y.Z., Moran, S.M., Hogenesch, J.B., Wartman, L., and Bradfield, C.A. 1998. Molecular characterization and chromosomal localization of a third α-class hypoxia inducible factor subunit, HIF3α. Gene Expr. 7: 205-213.
20. Gu, Y.Z., Hogenesch, J.B., and Bradfield, C.A. 2000. The PAS superfamily: Sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 40: 519-561.
21. Haase, V.H., Glickman, J.N., Socolovsky, M., and Jaenisch, R. 2001. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc. Natl. Acad. Sci. 98: 1583-1588.
22. Heacock, C.S. and Sutherland, R.M. 1990. Enhanced synthesis of stress proteins caused by hypoxia and relation to altered cell growth and metabolism. Br. J. Cancer 62: 217-225.
23. Hewitson, K.S., McNeill, L.A., Riordan, M.V., Tian, Y.M., Bullock, A.N., Welford, R.W., Elkins, J.M., Oldham, N.J., Bhattacharya, S., Gleadle, J.M., et al. 2002. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277: 26351-26355.
24. Hogenesch, J.B., Chan, W.K., Jackiw, V.H., Brown, R.C., Gu, Y.Z., Fray-Grant, M., Perdew, G.H., and Bradfield, C.A. 1997. Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway. J. Biol. Chem. 272: 8581-8593.
25. Hu, C.J., Wang, L.Y., Chodosh, L.A., Keith, B., and Simon, M.C. 2003. Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation. Mol. Cell. Biol. 23: 9361-9374.
26. Huang, Y., Hickey, R.P., Yeh, J.L., Liu, D., Dadak, A., Young, L.H., Johnson, R.S., and Giordano, F.J. 2004. Cardiac myocyte-specific HIF-1α deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. FASEB J. 18: 1138-1140.
27. Katschinski, D.M., Marti, H.H., Wagner, K.F., Shibata, J., Eckhardt, K., Martin, F., Depping, R., Paasch, U., Gassmann, M., Ledermann, B., et al. 2003. Targeted disruption of the mouse PAS domain serine/threonine kinase PASKIN. Mol. Cell. Biol. 23: 6780-6789.
28. Kondo, K., Kim, W.Y., Lechpammer, M., and Kaelin Jr., W.G., 2003. Inhibition of HIF2a is sufficient to suppress pVHL-defective tumor growth. PLoS Biol. 1: E83.
29. Koumenis, C., Naczki, C., Koritzinsky, M., Rastani, S., Diehl, A., Sonenberg, N., Koromilas, A., and Wouters, E.G. 2002. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2α. Mol. Cell. Biol. 22: 7405-7416.
30. Lando, D., Peet, D.J., Gorman, J.J., Whelan, D.A., Whitelaw, M.L., and Bruick, R.K. 2002a. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes & Dev. 16: 1466-1471.
31. Lando, D., Peet, D.J., Whelan, D.A., Gorman, J.J., and Whitelaw, M.L. 2002b. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295: 858-861.
32. Lopez-Barneo, J., del Toro, R., Levitsky, K.L., Chiara, M.D., and Ortega-Saenz, P. 2004. Regulation of oxygen sensing by ion channels. J. Appl. Physiol. 96: 1187-1195; discussion 1170-1182.
33. Mack, F.A., Rathmell, W.K., Arsham, A.M., Gnarra, J., Keith, B., and Simon, M.C. 2003. Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth. Cancer Cell 3: 75-88.
34. Mahon, P.C., Hirota, K., and Semenza, G.L. 2001. FIH-1: A novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity. Genes & Dev. 15: 2675-2686.
35. Makino, Y., Cao, R., Svensson, K., Bertilsson, G., Asman, M., Tanaka, H., Cao, Y., Berkenstam, A., and Poellinger, L. 2001. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414: 550-554.
36. Maltepe, E., Schmidt, J.V., Baunoch, D., Bradfield, C.A., and Simon, M.C. 1997. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386: 403-407.
37. Maxwell, P.H., Wiesener, M.S., Chang, G.W., Clifford, S.C., Vaux, E.G., Cockman, M.E., Wykoff, C.C., Pugh, C.W., Maher, E.R., and Ratcliffe, P.J. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275.
38. McMurtry, I.F., Bauer, N.R., Fagan, K.A., Nagaoka, T., Gebb, S.A., and Oka, M. 2003. Hypoxia and Rho/Rho-kinase signaling. Lung development versus hypoxic pulmonary hypertension. Adv. Exp. Med. Biol. 543: 127-137.
39. McNeill, L.A., Hewitson, K.S., Claridge, T.D., Seibel, J.F., Horsfall, L.E., and Schofield, C.J. 2002. Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the β-carbon of Asparagine-803. Biochem. J. 367: 571-575.
40. Mekhail, K., Gunaratnam, L., Bonicalzi, M.E., and Lee, S. 2004. HIF activation by pH-dependent nucleolar sequestration of VHL. Nat. Cell. Biol. 6: 642-647.
41. Miao, W., Luo, Z., Kitsis, R.N., and Walsh, K. 2000. Intracoronary, adenovirus-mediated Akt gene transfer in heart limits infarct size following ischemia-reperfusion injury in vivo. J. Mol. Cell. Cardiol. 32: 2397-2402.
42. Minamino, T. and Kourembanas, S. 2001. Mechanisms of telomerase induction during vascular smooth muscle cell proliferation. Circ. Res. 89: 237-243.
43. Minamino, T., Christou, H., Hsieh, C.M., Liu, Y., Dhawan, V., Abraham, N.G., Perrella, M.A., Mitsialis, S.A., and Kourembanas, S. 2001. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc. Natl. Acad. Sci. 98: 8798-8803.
44. Moeller, B.J., Cao, Y., Li, C.Y., and Dewhirst, M.W. 2004. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules. Cancer Cell 5: 429-441.
45. Ohh, M., Park, C.W., Ivan, M., Hoffman, M.A., Kim, T.Y., Huang, L.E., Pavletich, N., Chau, V., and Kaelin, W.G. 2000. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nat. Cell. Biol. 2: 423-427.
46. Park, S.K., Dadak, A.M., Haase, V.H., Fontana, L., Giaccia, A.J., and Johnson, R.S. 2003. Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1α (HIF-1α): Role of cytoplasmic trapping of HIF-2α. Mol. Cell. Biol. 23: 4959-4971.
47. Peng, Y.J. and Prabhakar, N.R. 2004. Effect of two paradigms of chronic intermittent hypoxia on carotid body sensory activity. J. Appl. Physiol. 96: 1236-1242; discussion 1196.
48. Peng, J., Zhang, L., Drysdale, L., and Fong, G.H. 2000. The transcription factor EPAS-1/hypoxia-inducible factor 2α plays an important role in vascular remodeling. Proc. Natl. Acad. Sci. 97: 8386-8391.
49. Potter, C. and Harris, A.L. 2004. Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target. Cell Cycle 3: 164-167.
50. Raj, U. and Shimoda, L. 2002. Oxygen-dependent signaling in pulmonary vascular smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 283: L671-L677.
51. Rapisarda, A., Uranchimeg, B., Scudiero, D.A., Selby, M., Sausville, E.A., Shoemaker, R.H., and Melillo, G. 2002. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res. 62: 4316-4324.
52. Rapisarda, A., Uranchimeg, B., Sordet, O., Pommier, Y., Shoemaker, R.H., and Melillo, G. 2004. Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: Mechanism and therapeutic implications. Cancer Res. 64: 1475-1482.
53. Rini, B.I., Halabi, S., Taylor, J., Small, E.J., and Schilsky, R.L. 2004. Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-α or interferon-α plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma. Clin. Cancer Res. 10: 2584-2586.
54. Schipani, E., Ryan, H.E., Didrickson, S., Kobayashi, T., Knight, M., and Johnson, R.S. 2001. Hypoxia in cartilage: HIF-1α is essential for chondrocyte growth arrest and survival. Genes & Dev. 15: 2865-2876.
55. Schofield, C.J. and Ratcliffe, P.J. 2004. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell. Biol. 5: 343-354.
56. Schroedl, C., McClintock, D.S., Budinger, G.R., and Chandel, N.S. 2002. Hypoxic but not anoxic stabilization of HIF-1a requires mitochondrial reactive oxygen species. Am. J. Physiol. Lung Cell. Mol. Physiol. 283: L922-L931.
57. Schumacker, P.T. 2003. Current paradigms in cellular oxygen sensing. Adv. Exp. Med. Biol. 543: 57-71.
58. -/- mice. Nat. Genet. 35: 331-340.
59. Semenza, G.L. 2003. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3: 721-732.
60. 2-regulated gene expression: Transcriptional control of cardiorespiratory physiology by HIF-1. J. Appl. Physiol. 96: 1173-1177; discussion 1170-1172.
61. Siemann, D.W., Chaplin, D.J., and Horsman, M.R. 2004. Vascular-targeting therapies for treatment of malignant disease. Cancer 100: 2491-2499.
62. Spencer, T.E., Jenster, G., Burcin, M.M., Allis, C.D., Zhou, J., Mizzen, C.A., McKenna, N.J., Onate, S.A., Tsai, S.Y., Tsai, M.J., et al. 1997. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389: 194-198.
63. Sutphin, P.D., Chan, D.A., and Giaccia, A.J. 2004. Dead cells don't form tumors: HIF-dependent cytotoxins. Cell Cycle 3: 160-163.
64. Tian, H., McKnight, S.L., and Russell, D.W. 1997. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes & Dev. 11: 72-82.
65. Tian, H., Hammer, R.E., Matsumoto, A.M., Russell, D.W., and McKnight, S.L. 1998. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes & Dev. 12: 3320-3324.
66. Vaupel, P. 2004. Tumor microenvironmental physiology and its implications for radiation oncology. Semin. Radiat. Oncol. 14: 198-206.
67. Vogel, J., Kiessling, I., Heinicke, K., Stallmach, T., Ossent, P., Vogel, O., Aulmann, M., Frietsch, T., Schmid-Schonbein, H., Kuschinsky, W., et al. 2003. Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity. Blood 102: 2278-2284.
68. Wang, G.L. and Semenza, G.L. 1995. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270: 1230-1237.
69. Waypa, G.B. and Schumacker, P.T. 2002. O(2) sensing in hypoxic pulmonary vasoconstriction: The mitochondrial door re-opens. Respir. Physiol. Neurobiol. 132: 81-91.
70. Yun, Z., Maecker, H.L., Johnson, R.S., and Giaccia, A.J. 2002. Inhibition of PPARg2 gene expression by the HIF-1-regulated gene DEC1/Stra13. A mechanism for regulation of adipogenesis by hypoxia. Dev. Cell 2: 331-341.